For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Insect cells offer high levels of protein expression with posttranslational modification approaching that of mammalian cells, ease of scale-up, and simplified cell growth that can be readily adapted to high-density suspension culture for large-scale expression. Most of the posttranslational modification pathways present in mammalian systems also occur in insect cells, allowing the production of recombinant protein that is more antigenically, immunogenically, and functionally similar to the native mammalian protein than if expressed in yeast or other eukaryotes.
Expression systems are genetic constructs (a gene encoded by DNA) that are designed to produce a protein, or an RNA (ribonucleic acid), either inside or outside a cell.
Insect Cell Expression Systems are powerful and versatile systems for producing high levels of recombinant protein expression in insect cells.
The Insect Cell Expression Systems market revenue was 237.06 Million USD in 2022, and will reach 439.4 Million USD in 2028, with a CAGR of 10.83% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Insect Cell Expression Systems industry, and breaks down according to the type, application, and consumption area of Insect Cell Expression Systems. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Insect Cell Expression Systems in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Insect Cell Expression Systems market covered in Chapter 11:
Oxford Expression Technologies
New England Biolabs
GenScript Biotech Corporation
Thermo Fisher Scientific
In Chapter 3, on the basis of types, the Insect Cell Expression Systems market from 2018 to 2028 is primarily split into:
In Chapter 4, on the basis of applications, the Insect Cell Expression Systems market from 2018 to 2028 covers:
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
Europe (Covered in Chapter 7)
Asia-Pacific (Covered in Chapter 8)
Middle East and Africa (Covered in Chapter 9)
South America (Covered in Chapter 10)
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028